Abstract
Atherosclerosis is one of the most common causes of death in developed countries. Atherosclerosis is an inflammatory process that results in the development of complex lesions or plaques that protrude into the arterial lumen. Plaque rupture and thrombosis result in the acute clinical complications of myocardial infarction and stroke. Although certain risk factors (dyslipidemias, diabetes, hypertension) and humoral markers of plaque vulnerability (C-reactive protein, interleukin-6, -10 and -18, CD-40L) have been identified, a highly sensitive and specific biomarker or protein profile, which could provide information on the stability/vulnerability of atherosclerotic lesions, remains to be identified. Recently, we have described a novel strategy consisting in the proteomic analysis of proteins released by normal and atherosclerotic arterial walls in culture. This method enables harvesting of proteins that are only secreted by pathological or normal arterial walls. By focusing only on the secreted proteins found in the tissue culture media, there is an intended bias toward those molecules that would have a higher probability of later being found in plasma. Using this approach, we have shown that carotid atherosclerotic plaques cultured in vitro are able to secrete proteins, and also that a differential pattern of protein secretion of normal arteries vs pathological ones has been observed. In this chapter, the proteomic analysis of the human atheroma plaque secretome is described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Murray, C. J. and Lopez, A. D. (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349, 1436–1442.
Hansson, G. K. (2005) Inflammation, atherosclerosis and coronary artery disease. N. Engl. J. Med. 352, 1685–1695.
Kuang-Yuh Chyu, P. S. (2001) The role of inflammation in plaque disruption and thrombosis. Rev. Cardiovasc. Med. 2, 82–91.
Davies, M. J. (2001) Going from immutable to mutable atherosclerotic plaques. Am. J. Cardiol. 88, 2F–9F.
Kolodgie, F. D., Virmani, R., Burke, A. P., et al. (2004) Pathologic assessment of the vulnerable human coronary plaque. Heart 90, 1385–1391.
Stary, H. C., Chandler, A. B., Glagov, S., et al. (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89, 2462–2478.
Mayr, M., Mayr, U., Chung, Y. L., Yin, X., Griffiths, J. R., and Xu, Q. (2004) Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 4, 3751–3761.
Stastny, J., Fosslien, E., and Robertson, A. L., Jr. (1986) Human aortic intima protein composition during initial stages of atherogenesis. Atherosclerosis 60, 131–139.
You, S. A., Archacki, S. R., Angheloiu, G., et al. (2003) Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol. Genomics 13, 25–30.
Fach, E., Garulacan, L., Gao, J., et al. (2004) In vitro biomarker discovery for atherosclerosis by proteomics. Mol. Cell. Proteomics 3, 1200–1210.
Duran, M. C., Mas, S., Martín-Ventura, J. L., et al. (2003) Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics 3, 973–978.
Duran, M. C., Martin-Ventura, J. L., Mohammed, S., et al. (2005) The elucidation of atherosclerotic plaque secretome by proteomic analysis: a potential strategy for detection and characterization of proteins involved in plaque formation and rupture (in revision).
Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72, 248–254.
Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, novel approach to testing for induced point mutations in mammals. Nature 227, 680–685.
Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 68, 850–858.
Meiring, H. D., Van der Helft, E., TenHove, G. J., and DeJong, A. P. (2002) Nanoscale LC-MS(n): technical design and application to peptide and protein analysis. J. Sep. Sci. 25, 557–568.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Durán, MC. et al. (2007). Characterization of the Human Atheroma Plaque Secretome by Proteomic Analysis. In: Vivanco, F. (eds) Cardiovascular Proteomics. Methods in Molecular Biology™, vol 357. Humana Press. https://doi.org/10.1385/1-59745-214-9:141
Download citation
DOI: https://doi.org/10.1385/1-59745-214-9:141
Publisher Name: Humana Press
Print ISBN: 978-1-58829-535-4
Online ISBN: 978-1-59745-214-4
eBook Packages: Springer Protocols